Breast Cancer

Cindi Cantril, RN, OCN, MPH, remembers only the eyes of her patients.

Debu Tripathy, editor-in-chief of CURE and chair of the Department of Breast Medical Oncology at The University of Texas MD Anderson Cancer Center, discusses adding the targeted drug Ibrance to the hormonal drug Faslodex.

Some days it's just a day to cry. But that's OK.

Has cancer changed your perspective on life? What do you value most? What do you most desire?

It is my five-year breast cancer anniversary and I will celebrate because I am here.

Data from a new report that shows compelling information on physicians who use Twitter, types of cancer, and ways to assess integrity.

By adding the targeted drug Ibrance to the hormonal drug Faslodex, women with previously treated hormone receptor (HR)-positive, HER2-negative breast cancer delayed disease progression by more than five months.

In a new study, weight training was shown to help stave off deterioration of physical function in breast cancer survivors, conferring a benefit twice that of women in a control group.

A breast cancer survivor shares ways she copes with fear of recurrence while waiting for her latest mammogram results.

Mending from cancer and its treatment takes time. It's not always easy to let your body set the pace for recovery.

Herceptin has been one of the most remarkable breakthroughs in treating breast cancer — but it can cause cardiac issues.

Early action to diagnose and treat lymphedema after breast cancer treatment can reverse this side effect or prevent it from becoming more severe.

The best gift a friend can offer to someone who is ill is quiet comfort and support.

Breast cancer survivor shares her radiation treatment experience and offers tips from her perspective.

Cancer is just an unlucky accident, so stop blaming yourself.

A breast cancer and melanoma survivor reflects on the emotions and experiences after surgeries, chemotherapy and radiation are completed.

Understanding and classifying tumors based on their genomic makeup is an essential component of precision medicine.

Tears are a normal part of the cancer struggle. Is hiding them isolating you and making it harder to get the support you deserve?

A two-pronged strategy combining the PARP inhibitor Lynparza and the PI3K inhibitor BKM120 proved to be a safe and clinically beneficial regimen for women with TNBC and for patients with high-grade serous ovarian cancer.

A breast cancer and melanoma survivor shares her thoughts on time as well as her biopsy results.

Imagine a woman with a weight problem who, two weeks after chemotherapy, goes to her doctor with a urinary tract infection and a rash on her upper chest.

A breast cancer and melanoma survivor shares her perspective on living with "wait and watch."

A recent study enrolled 1,589 black women and 1,256 white women who underwent screening mammography at the University of Pennsylvania from 2010 to 2011.

It's easy to feel alone dealing with cancer. Being a part of a social media community that "gets it" can be invaluable to healing.

Everyone's chemotherapy experience is unique.

MM-302, a novel antibody-drug conjugate that specifically targets cancer cells overexpressing the HER2 receptor, showed signs of clinical activity in heavily pretreated patients with metastatic, HER2-positive breast cancer.

Cancer Survivors Beauty and Support Day is an annual event on the first Tuesday in June where those in the beauty industry volunteer services to cancer patients and survivors.

The PALOMA-3 trial examining an Ibrance (palbociclib) regimen in HR-positive/HER2-negative breast cancer was halted after an independent panel determined it met the primary endpoint of improving progression-free survival.

A new telephone-based intervention for breast cancer survivors is showing promise, and it involves them becoming more actively engaged in goal setting and problem solving with an eye toward accelerating their recovery by engaging in health-promoting activities such as exercise, stress management and healthy eating.

Breast cancer patients with diabetes were significantly more likely to be diagnosed with advanced-stage breast cancer than those without diabetes.